World-first blood test for brain cancer may increase survival rates, say experts ( www.theguardian.com )

Inexpensive test can help diagnose even ‘inaccessible’ tumours earlier, speeding up treatment and improving outcomes

Surgeons and scientists have developed a world-first blood test for brain cancer that experts say could revolutionise diagnosis, speed up treatment and boost survival rates.

For years, brain tumours have remained notoriously difficult to diagnose. They affect hundreds of thousands of people worldwide each year, and kill more children and adults under the age of 40 in the UK than any other cancer.

Now a research team has designed a simple blood test that could help diagnose patients with even the deadliest forms of brain cancer much more quickly, potentially sparing them from invasive and high-risk surgical biopsies. The breakthrough was reported in the International Journal of Cancer.

Experts said the inexpensive liquid biopsy could also lead to earlier diagnosis, which in turn would speed up treatment and potentially increase survival rates. The test would be particularly beneficial for patients with “inaccessible” brain tumours, who could benefit from starting treatment as soon as possible, they added.